| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |